首页> 外文期刊>EFSA Journal >Scientific Opinion on the safety and efficacy of L‐threonine produced by Escherichia coli strains NRRL B‐30843, DSM 26131, KCCM11133P or DSM 25085 for all animal species based on a dossier submitted by AMAC EEIG
【24h】

Scientific Opinion on the safety and efficacy of L‐threonine produced by Escherichia coli strains NRRL B‐30843, DSM 26131, KCCM11133P or DSM 25085 for all animal species based on a dossier submitted by AMAC EEIG

机译:关于基于AMAC EEIG提交的档案的大肠杆菌NRRL B-30843,DSM 26131,KCCM11133P或DSM 25085大肠杆菌生产的L-苏氨酸的安全性和有效性的科学意见

获取原文
           

摘要

This opinion concerns L‐threonine as a feed additive produced by four different strains derived from Escherichia coli K‐12. Three strains are genetically modified (GM): NRRL B‐30843, KCCM11133P and DSM 26131. L‐Threonine produced by E. coli DSM 26131 could not be assessed because of the insufficient molecular characterisation of the genetic modification, and the lack of data on both the absence of the production strain and its recombinant DNA from the final product. No safety concerns were found in the products related to the genetic modification of the other GM strains or to antibiotic resistance of the producer strains. L‐Threonine products made by fermentation using E. coli strains NRRL B‐30843, KCCM11133P and DSM 25085 are free of the production strain and have a high purity (≥ 98.8 %). L‐Threonine, technically pure, produced by E. coli strains NRRL B‐30843, KCCM11133P and DSM 25085 is safe for the target animals when used in appropriate amounts to supplement threonine‐deficient feeds, for the consumer of animal products and for the environment. The FEEDAP Panel considers that L‐threonine produced by E. coli strains NRRL B‐30843, KCCM11133P or DSM 25085 is not an irritant to eyes and skin, and is not a skin sensitiser. There is no risk from inhalation of L‐threonine, but concerns may arise from the content of endotoxins in the products. These L‐threonine products are considered an efficacious source of the amino acid L‐threonine for all animal species. For L‐threonine to be as efficacious in ruminants as in non‐ruminant species, it requires protection against degradation in the rumen. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) has concerns regarding the safety of the simultaneous oral administration of L‐threonine via water for drinking and feed.
机译:这种意见涉及左旋苏氨酸作为饲料添加剂,是由源自大肠杆菌K-12的四种不同菌株产生的。已对三种菌株进行了基因修饰(GM):NRRL B-30843,KCCM11133P和DSM26131。由于基因修饰的分子表征不足,并且缺乏有关转基因的数据,因此无法评估大肠杆菌DSM 26131产生的L-苏氨酸。既没有生产菌株,也没有来自最终产品的重组DNA。在产品中未发现与其他GM菌株的基因修饰或生产菌株的抗生素抗性有关的安全问题。使用大肠杆菌NRRL B-30843,KCCM11133P和DSM 25085菌株进行发酵生产的L-苏氨酸产品不含生产菌株,并且纯度高(≥98.8%)。由大肠杆菌NRRL B-30843,KCCM11133P和DSM 25085菌株生产的技术纯的L-苏氨酸对目标动物是安全的,如果适量使用以补充苏氨酸不足的饲料,对于动物产品的消费者和环境。 FEEDAP小组认为,由大肠杆菌NRRL B-30843,KCCM11133P或DSM 25085菌株生产的L-苏氨酸对眼睛和皮肤没有刺激性,也不是皮肤致敏剂。吸入L-苏氨酸没有危险,但产品中内毒素的含量可能引起关注。这些L-苏氨酸产物被认为是所有动物物种氨基酸L-苏氨酸的有效来源。为了使L-苏氨酸在反刍动物中的功效与在非反刍动物中的功效相同,需要防止其在反刍动物中的降解。动物饲料中使用的添加剂和产品或物质小组(FEEDAP)对通过饮用水和饲料同时口服L-苏氨酸的安全性表示担忧。

著录项

  • 来源
    《EFSA Journal》 |2015年第9期|共34页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 食品工业;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号